Holen Sie sich die Stockscreener-App
535.38
1.15%
6.09
Handel nachbörslich:
535.38
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$529.29
Offen:
$522.05
24-Stunden-Volumen:
405.85K
Relative Volume:
0.66
Marktkapitalisierung:
$42.18B
Einnahmen:
$4.45B
Nettoeinkommen (Verlust:
$1.10B
KGV:
39.39
EPS:
13.591
Netto-Cashflow:
$1.06B
1W Leistung:
-3.53%
1M Leistung:
-8.96%
6M Leistung:
-17.47%
1J Leistung:
-16.40%
1-Tages-Spanne:
$522.05
$536.09
1-Wochen-Bereich:
$522.05
$561.24
52-Wochen-Spanne:
$518.55
$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Firmenname
Idexx Laboratories Inc
Sektor
Branche
Telefon
(207) 556-0300
Adresse
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX vs TMO, DHR, NTRA, IQV, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
535.38 | 43.00B | 4.45B | 1.10B | 1.06B | 13.59 |
TMO
Thermo Fisher Scientific Inc
|
613.78 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
207.66 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
328.18 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
267.77 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
150.86 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Eingeleitet | Citigroup | Neutral |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-10-31 | Hochstufung | Stifel | Hold → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-08-05 | Bestätigt | BTIG Research | Buy |
| 2025-07-01 | Eingeleitet | Jefferies | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-12-04 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-21 | Hochstufung | Goldman | Neutral → Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-05-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-08 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-02-17 | Eingeleitet | Barclays | Overweight |
| 2019-09-09 | Eingeleitet | Goldman | Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2018-11-02 | Bestätigt | BofA/Merrill | Buy |
| 2018-05-07 | Bestätigt | Stifel | Buy |
| 2018-01-16 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-08-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Hochstufung | CL King | Neutral → Buy |
| 2017-02-03 | Herabstufung | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Fortgesetzt | BofA/Merrill | Neutral |
| 2016-08-16 | Bestätigt | Stifel | Buy |
| 2016-08-03 | Hochstufung | Northcoast | Sell → Neutral |
| 2016-07-20 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-19 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-01 | Eingeleitet | CL King | Neutral |
| 2016-03-21 | Bestätigt | Stifel | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2015-10-29 | Bestätigt | Stifel | Buy |
| 2015-08-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Bestätigt | Stifel | Buy |
| 2015-07-23 | Bestätigt | Canaccord Genuity | Buy |
Alle ansehen
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
IDEXX Laboratories stock holds near recent highs as diagnostics demand supports growth - AD HOC NEWS
Down 16% in the Last 12 Months, Can IDEXX Stock Bounce Back in 2027? - TIKR.com
Veterinary Diagnostic Markets Report Now Available — See Exactly How IDEXX, Zoetis, Antech, Roche, and Thermo Fisher Are Positioned to Win Through 2030 - GlobeNewswire Inc.
IDEXX Laboratories stock gains after strong Q2 results and raised 2026 outlook - AD HOC NEWS
ETFs Investing in IDEXX Laboratories, Inc. Stocks - tradingview.com
IDXX: Idexx Laboratories Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
IDEXX Laboratories stock steadies after strong Q2 2026 results and raised outlook - AD HOC NEWS
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors - MarketWatch
IDEXX Laboratories stock holds firm as investors eye earnings history - AD HOC NEWS
Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IDEXX Laboratories stock holds firm after earnings beat - AD HOC NEWS
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Resilient IDEXX Laboratories stock holds above $550 as earnings beat supports guidance - AD HOC NEWS
IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - Yahoo Finance
IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day - MarketWatch
IDEXX Laboratories Inc. (IDXX) Peer Comparison – Compare with Others - Value Research
Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink? - Barchart.com
Insider Decision: Andrew Emerson Exercises Options At IDEXX Laboratories For $101K - Benzinga
IDEXX Laboratories, Inc. (IDXX) Stock Report: Analyzing a 25.50% Potential Upside for Savvy Investors - DirectorsTalk Interviews
IDEXX Laboratories stock holds high valuation as earnings outlook firms - Ad-hoc-news.de
Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now? - TradingView
IDEXX launches first dual-species point-of-care NT-proBNP test for cardiac disease in cats and dogs - DVM360
Rationale Behind Baron Focused Growth Fund’s IDEXX Laboratories (IDXX) Holding - Yahoo Finance
Flossbach Von Storch SE Invests $9.09 Million in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Danske Bank A S Buys New Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $665 - 富途牛牛
Resilient IDEXX Laboratories stock trades in the mid-$550s as investors weigh premium valuation and - Ad-hoc-news.de
IDXX (IDEXX Laboratories) Cash Flow from Operations : $1,372 Mil (TTM As of Jun. 2026) - GuruFocus
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
IDEXX Laboratories stock holds above the mid-$540s as valuation stays demanding - Ad-hoc-news.de
IDXX (IDEXX Laboratories) Cash From Discontinued Investing Activities : $0 Mil (TTM As of Jun. 2026) - GuruFocus
Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999. - marketscreener.com
Plato Investment Management Ltd Takes $1.48 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Labs Executing, But Valuation Continues To Weigh On That Execution (NASDAQ:IDXX) - Seeking Alpha
Weekly Recap: AI diagnostics expansion and Barclays trims target to $710 - TradingView
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unpacking a 26.86% Potential Upside in the Diagnostics & Research Sector - DirectorsTalk Interviews
IDEXX Laboratories Inc (IDXX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Transamerica Large Core ESG's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
IDXX Stock Price and Chart — NASDAQ:IDXX - tradingview.com
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests - MarketBeat
IDEXX Laboratories, Inc. (IDXX) Analyst/Investor DaySlideshow (NASDAQ:IDXX) 2026-08-14 - Seeking Alpha
Handelsbanken Fonder AB Grows Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. (IDXX) Stock forecasts - Yahoo Finance Singapore
IDEXX Laboratories Inc (IDXX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo Finance
IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment - marketscreener.com
IDEXX launches in-clinic cardiac test for cats and dogs - Investing.com
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Idexx Laboratories Inc-Aktie (IDXX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| FENNELL GEORGE | Executive Vice President |
Jun 01 '26 |
Option Exercise |
0.00 |
639 |
0 |
10,717 |
0.59%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):